American Healthcare REIT Executive Sells 2,000 Shares for $111,000
Key Points
The transaction was valued at approximately $111,000.
The traded shares were equal to 4% of the stake held before the filing, resulting in 51,617 shares remaining.
The sale was conducted through direct ownership.
Mark E. Foster, EVP, GC & Secretary of American Healthcare REIT (NYSE:AHR), sold 2,000 shares of common stock on Sept. 1, 2026, according to a recent SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $111,000 |
| Shares sold | 2,000 |
| Post-transaction shares (directly held) | 51,617 |
| Post-transaction value | $2.9 million |
Transaction value based on SEC Form 4 weighted average sale price ($55.39); post-transaction value based on Sept. 01, 2026, market close ($56.54).
Key questions
- Under what conditions was this transaction executed?
The sale was performed according to a Rule 10b5-1 trading plan that Foster adopted on Dec. 19, 2025. Such plans are designed to allow corporate insiders to sell a predetermined number of shares at a predetermined time to mitigate concerns regarding potential material non-public information. - Were there any regulatory restrictions affecting this sale?
The filing indicates that this transaction was made pursuant to an exception to a lock-up agreement. This agreement was established between Foster and the underwriters of the company's common stock offering, which concluded on Aug. 12, 2026. - What does the current equity position of the executive look like?
Following this disposition of 2,000 shares, Foster continues to hold 51,617 shares directly. This equity stake represents approximately 0.02% of the company and is valued at $2.9 million based on the market close price as of the transaction date. - Does the executive hold other forms of equity in the company?
The current filing reports that Foster's direct holdings include 622 shares that were previously acquired through the company's Employee Stock Purchase Plan. No additional indirect holdings or derivative securities were detailed in this specific transaction report.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-31) | $55.21 |
| Market Capitalization | $12.5 billion |
| Revenue (TTM) | $2.5 billion |
| Net Income (TTM) | $121 million |
Company Snapshot
- American Healthcare REIT generates revenue through the ownership and leasing of healthcare facilities, including medical office buildings, hospitals, and other healthcare-related properties.
- The company operates as a real estate investment trust (REIT) that acquires, owns, and manages healthcare properties, generating income through lease payments from healthcare operators and providers while maintaining and enhancing its diversified portfolio.
- AHR's primary customers are healthcare operators, hospital systems, and medical service providers who lease facilities from the company, with a focus on serving the healthcare sector across multiple geographic markets.
American Healthcare REIT is a leading global REIT established through the strategic consolidation of Griffin-American Healthcare REIT III, Griffin-American Healthcare REIT IV, and American Healthcare Investors, positioning the company as a significant player in healthcare real estate with a $12.5 billion market capitalization. The company's diversified portfolio of healthcare properties and operational scale provides a competitive advantage in generating stable, recurring lease-based revenue streams. With TTM revenue of $2.5 billion and net income of $121 million, AHR demonstrates the financial strength and profitability characteristic of a mature healthcare real estate platform.
What this transaction means for investors
On Sept. 1, Foster sold 2,000 shares of American Healthcare REIT for approximately $111,000. Looking into the details of this transaction and how the stock price has performed, there doesn't appear to be any reason for shareholders to be worried. This transaction was part of a trading plan established all the way back in December 2025, so it wasn't a spur-of-the-moment decision by Foster.
In addition, although Foster sold 2,000 shares, he still holds 51,617 shares. That shows continued alignment with the company and its future success. Also, this transaction in and of itself doesn't give shareholders anything to worry about, as the stock price has performed exceptionally well. Over the last five years, the American Healthcare REIT stock price has risen nearly 310% as of this writing, while the S&P 500 has risen 71.2%. More recently, AHR shares are up 25.2% over the past 12 months.
Adding everything together, through the established trading plan to the extensive holdings Foster still retains, this transaction is something shareholders shouldn't worry about.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.